Manufacturer
6 recalls in our database name G & W Laboratories, Inc. as the manufacturing or recalling firm.
Of the 6 recalls from G & W Laboratories, Inc. we have scored against our rubric, 0 (0%) are Critical — deaths or serious injuries reported, or the agency’s own highest classification — and 1 (17%) are Severe.
The manufacturer string comes from the agency’s own source notice — for FDA recalls, the “recalling firm” field; for NHTSA recalls, the vehicle manufacturer; for CPSC recalls, the firm-of-record on the joint press release. A single corporate family can appear under multiple manufacturer strings as agency notices aren’t standardized on a canonical name. If you don’t see recalls you expect, try a parent-company search or a broader full-text search.
Severity scores below are computed from the agency’s classification and the recall text, never from manufacturer behaviour or history. Many manufacturers issue routine corrective actions (software updates, labelling corrections) that are correctly scored low — having recalls on this list isn’t inherently a quality signal.
G & W Laboratories is recalling 142,236 tubes of Ciclopirox Olamine Cream USP, 0.77%, due to yellow discoloration. The product is distributed nationwide and in Puerto Rico.
G & W Laboratories is recalling Clobetasol Propionate Ointment 0.05% due to out-of-specification results for a known impurity.
G & W Laboratories is recalling 230,700 tubes of Ciclopirox Olamine Cream because some lots were packaged with an out-of-date package insert.
G&W Laboratories is recalling specific lots of Clindamycin Phosphate Topical Solution because an expired active ingredient was used during manufacturing.
G&W Laboratories is recalling Indocin suppositories due to out-of-specification impurity results found during stability testing.
G & W Laboratories is recalling Fluocinolone Acetonide Cream 0.025% because it failed content uniformity specifications at the 18-month time point.